Senior Director, Global Medical Affairs, Lung

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑added cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Reporting to the Lung Cancer Medical Affairs Strategy Lead, the Senior Director, Global Medical Affairs, will be responsible for developing and executing the Global Medical Affairs (GMA) strategy and tactical plans with a focus on launch readiness and life cycle management for an individual asset. The successful candidate will have a proven track record of developing and driving medical strategy with a focus on effectively communicating key scientific data through publications, medical information, medical communications, and congress activities as well as gathering insights through Advisory Boards and Key Opinion Leader (KOL) engagements.

They must work collaboratively with cross‑functional counterparts in Development, Research and Commercial as well as other partners in the organization to design and implement a comprehensive NSCLC strategy.

• Leads the development and execution of the GMA strategy and medical objectives including activities related to scientific engagement and communication, evidence generation, internal education, and patient advocacy.
• Leads the development and execution of a Health Care Professional (HCP) engagement strategy to gather insights to shape internal programs.
• Acts as the medical representative on cross‑functional teams.
• Serves as a therapeutic area content expert.
• Participates in the Global Medical Affairs Team (GMAT) to execute medical strategies, contribute to the operations and oversight of medical activities, and work cross‑functionally to support associated pre‑launch activities.
• Contributes to the execution of routine gap assessments leading to the development/refinement of a publication strategy, an evidence generation plan, and tactical plan as part of the overall GMA plan.
• Provides medical leadership in scientific engagement activities with key external stakeholders through organizing and leading advisory boards, study investigator interactions, congress activities, and peer‑to‑peer discussions with the goal of communicating scientific insights to internal teams to drive strategy.
• Communicates clinical and scientific data to KOLs and other healthcare professionals through presentations, educational programs, and scientific discussions.
• Represents various medical affairs functions in cross‑functional strategy team meetings including Clinical and Safety sub‑teams, Global Brand Team, Global Product Team, Patient Advocacy, Market Access, and other cross‑functional strategic discussions.
• Partners with the Clinical and MSL teams to provide enrollment, scientific, and engagement support to ensure clinical trials meet study timelines.
• Partners with RWE strategy and Biomarker/CDx teams on related integrated evidence generation strategies and activities as part of the GMA Plan.
• Partners with the Patient Advocacy and Grants teams to incorporate the patient voice and define external medical education strategies for independent grants.
• Provides medical expertise for scientific symposia and medical congresses and collaborate across GMA functions to develop, review, and align on key scientific communication points and medical information response documents within legal and compliance guidelines.
• Plays a key role in the review and approval of abstracts, manuscripts, corporate communications, and other data disclosure documents as well as internal stakeholder medical education activities related to the compound data and related competitor data.
• Partners with stakeholders across the organization, including, but not limited to, Clinical Development and Operations, Commercial Operations, Program…